MedTrace Logo

Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

NCT02827734 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-03-24

No results posted yet for this study

Summary

Current diagnostic tools used in interstitial lung disease (ILD) do not meet the challenges set by the complex pathophysiology of this heterogenous group. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of patients with various ILDs.

Conditions

Interventions

DEVICE

multiple breath washout tests

DEVICE

impulse oscillometry

DEVICE

body plethysmography

Sponsors & Collaborators

  • Universitätsmedizin Mannheim

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02827734 on ClinicalTrials.gov